000 | 01958 a2200565 4500 | ||
---|---|---|---|
005 | 20250516031722.0 | ||
264 | 0 | _c20110720 | |
008 | 201107s 0 0 eng d | ||
022 | _a1744-8042 | ||
024 | 7 |
_a10.2217/pgs.10.189 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPerroud, Nader | |
245 | 0 | 0 |
_aClinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. _h[electronic resource] |
260 |
_bPharmacogenomics _cMar 2011 |
||
300 |
_a365-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
650 | 0 | 4 |
_aClomipramine _xadverse effects |
650 | 0 | 4 |
_aCyclohexanols _xadverse effects |
650 | 0 | 4 |
_aDepressive Disorder _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Association Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParoxetine _xadverse effects |
650 | 0 | 4 | _aPiperazines |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT1B _xgenetics |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSuicidal Ideation |
650 | 0 | 4 |
_aTacrolimus Binding Proteins _xgenetics |
650 | 0 | 4 |
_aTriazoles _xadverse effects |
650 | 0 | 4 | _aVenlafaxine Hydrochloride |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBondolfi, Guido | |
700 | 1 | _aUher, Rudolf | |
700 | 1 | _aGex-Fabry, Marianne | |
700 | 1 | _aAubry, Jean-Michel | |
700 | 1 | _aBertschy, Gilles | |
700 | 1 | _aMalafosse, Alain | |
700 | 1 | _aKosel, Markus | |
773 | 0 |
_tPharmacogenomics _gvol. 12 _gno. 3 _gp. 365-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.10.189 _zAvailable from publisher's website |
999 |
_c20718606 _d20718606 |